Phibro Acquires Zoetis' Medicated Feed Additive Business

Zoetis Completes Acquisition of Jurox

September 30, 2022

Pharmaceuticals

Zoetis Inc. has completed its acquisition of Jurox, a privately held Australian animal health company that develops, manufactures and markets veterinary medicines, including the anaesthetic Alfaxan. The deal expands Zoetis' veterinary product portfolio and manufacturing capabilities in Australia and supports greater global distribution of Jurox products.

Dechra Pharmaceuticals Acquires Med-Pharmex from DW Healthcare Partners

August 30, 2022

Veterinary

Dechra Pharmaceuticals PLC has completed the acquisition of Med-Pharmex Holdings, Inc. from DW Healthcare Partners. The deal brings a US-based, fully integrated veterinary pharmaceutical manufacturer (Med-Pharmex) into Dechra's global animal-health platform to strengthen its manufacturing capabilities and North American footprint.

DW Healthcare Partners Invests in Bio Agri Mix

July 27, 2021

Veterinary

DW Healthcare Partners completed an investment in Bio Agri Mix LP, Canada’s largest manufacturer and distributor of medicated feed additives and water-soluble animal medications. As part of the transaction DWHP partners join Bio Agri Mix’s board and will support expansion of the company’s product portfolio and growth across the North American livestock market.

Swedencare AB (publ) Acquires Animal Pharmaceuticals Inc.

September 24, 2020

Veterinary

Swedencare AB (publ) acquired the operations of US-based Animal Pharmaceuticals Inc. for an initial purchase price of USD 15 million (approx. 131 million SEK) plus a potential earnout of up to USD 10 million; consideration includes cash and a directed new share issue. The deal (closed via newly established US subsidiary Animal Pharm Care USA, Inc.) adds a portfolio of supplements and topical veterinary products sold to ~8,500 US veterinary clinics and positions founder Jason Braun to lead the business and become a major Swedencare shareholder.

Wedgewood Pharmacy (New Harbor Capital) Acquires Leiters Enterprises' San Jose 503B Assets and Wildlife Pharmaceuticals (ZooPharm)

June 17, 2020

Veterinary

Wedgewood Pharmacy, a portfolio company of New Harbor Capital, has reached definitive agreements to acquire the San Jose, California assets of Leiters Enterprises (a 22,000 sq ft FDA-registered 503B outsourcing facility) and to acquire Wildlife Pharmaceuticals, Inc. and its subsidiary ZooPharm. The 503B facility will operate as Wedgewood Connect and is expected to begin releasing select sterile injectables and ophthalmics in Q4 2020; both transactions are subject to closing timelines and regulatory approvals.

Zoetis Acquires Platinum Performance

August 14, 2019

Veterinary

Zoetis Inc. has completed the acquisition of Platinum Performance, a privately held, nutrition-focused animal health company based in Buellton, California. Platinum Performance will operate as a wholly owned subsidiary of Zoetis and continue to be led by Mark Herthel from its Buellton headquarters; financial terms were not disclosed.